These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 883333)
1. Adjuvant combination chemotherapy with CMF in primary mammary carcinoma. Veronesi U; Rossi A; Bonadonna G World J Surg; 1977 May; 1(3):337-40. PubMed ID: 883333 [No Abstract] [Full Text] [Related]
2. Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program. Rossi A; Bonadonna G; Valagussa P; Veronesi U Recent Results Cancer Res; 1977; (62):134-42. PubMed ID: 341246 [No Abstract] [Full Text] [Related]
3. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made? Levitt SH; Potish RA Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy in the primary management of breast cancer. Fisher B Med Clin North Am; 1977 Sep; 61(5):953-65. PubMed ID: 330977 [No Abstract] [Full Text] [Related]
5. Present status of CMF adjuvant therapy in operable breast cancer. Bonadonna G Int J Radiat Oncol Biol Phys; 1977; 2(3-4):237-40. PubMed ID: 324955 [No Abstract] [Full Text] [Related]
6. [Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles]. Sismondi P; Zola P; Galletto L; De Giovanni D; Giardina G Minerva Ginecol; 1979; 31(7-8):563-8. PubMed ID: 481814 [No Abstract] [Full Text] [Related]
7. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer. Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522 [TBL] [Abstract][Full Text] [Related]
8. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer. Rossi A; Valagussa P; Bonadonna G Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401 [No Abstract] [Full Text] [Related]
9. Grand Rounds: Adjuvant therapy of breast cancer. Va Med; 1977 Oct; 104(10):709-15. PubMed ID: 919723 [No Abstract] [Full Text] [Related]
10. [Combination chemotherapy in advanced carcinoma of the breast]. Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643 [No Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501 [TBL] [Abstract][Full Text] [Related]
12. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Bonadonna G; Rossi A; Valagussa P; Banfi A; Veronesi U Cancer; 1977 Jun; 39(6 Suppl):2904-15. PubMed ID: 326384 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279 [TBL] [Abstract][Full Text] [Related]
14. [Adjuvant chemotherapy in breast cancer]. Senn HJ Dtsch Med Wochenschr; 1981 Nov; 106(48):1626-30. PubMed ID: 7030686 [No Abstract] [Full Text] [Related]
15. Multimodal treatment in operable breast cancer: five-year results of the CMF programme. Rossi A; Bonadonna G; Valagussa P; Veronesi U Br Med J (Clin Res Ed); 1981 May; 282(6274):1427-31. PubMed ID: 6784849 [TBL] [Abstract][Full Text] [Related]
16. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L; J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260 [TBL] [Abstract][Full Text] [Related]
17. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B; J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406 [TBL] [Abstract][Full Text] [Related]